Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Adverse effects: diplopia · people with drug‐resistant focal epilepsy

Rufinamide may leads to higher adverse effects: diplopia compared with placebo (low certainty).

1 finding from 1 review

Rufinamide add‐on therapy for drug‐resistant epilepsy 2020 · Cochrane Headline outcomes only
RR 4.6 [2.53, 8.38]
3 studies · 1295 participants
Low